Open access · CC-BY
via OpenAlex
Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain
Rosalind F. Roberts, Richard Wade‐Martins, Javier Alegre‐Abarrategui
Brain · 2015 · ▲ 277 citations
Abstract
Oligomeric forms of alpha-synuclein are emerging as key mediators of pathogenesis in Parkinson's disease. Our understanding of the exact contribution of alpha-synuclein oligomers to disease is limited by the lack of a technique for their specific detection. We describe a novel method, the alpha-synuclein proximity ligation assay, which specifically recognizes alpha-synuclein oligomers. In a blinded study with post-mortem brain tissue from patients with Parkinson's disease (n = 8, age range 73-92 years, four males and four females) and age- and sex-matched controls (n = 8), we show that the alpha-synuclein proximity ligation assay reveals previously unrecognized pathology in the form of extensive diffuse deposition of alpha-synuclein oligomers. These oligomers are often localized, in the absence of Lewy bodies, to neuroanatomical regions mildly affected in Parkinson's disease. Diffuse alpha-synuclein proximity ligation assay signal is significantly more abundant in patients compared to controls in regions including the cingulate cortex (1.6-fold increase) and the reticular formation of the medulla (6.5-fold increase). In addition, the alpha-synuclein proximity ligation assay labels very early perikaryal aggregates in morphologically intact neurons that may precede the development of classical Parkinson's disease lesions, such as pale bodies or Lewy bodies. Furthermore, the alpha-synuclein proximity ligation assay preferentially detects early-stage, loosely compacted lesions such as pale bodies in patient tissue, whereas Lewy bodies, considered heavily compacted late lesions are only very exceptionally stained. The alpha-synuclein proximity ligation assay preferentially labels alpha-synuclein oligomers produced in vitro compared to monomers and fibrils, while stained oligomers in human brain display a distinct intermediate proteinase K resistance, suggesting the detection of a conformer that is different from both physiological, presynaptic alpha-synuclein (proteinase K-sensitive) and highly aggregated alpha-synuclein within Lewy bodies (proteinase K-resistant). These disease-associated conformers represent previously undetected Parkinson's disease pathology uncovered by the alpha-synuclein proximity ligation assay.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/brain/awv040
- Canonical
- link ↗
- Fetched
- 2026-06-03 MST
Cite this
APA
Roberts, R.F., Wade‐Martins, R., & Alegre‐Abarrategui, J. (2015). Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain. <em>Brain</em>. https://doi.org/10.1093/brain/awv040
Vancouver
Roberts RF, Wade‐Martins R, Alegre‐Abarrategui J. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain. Brain. 2015. doi:10.1093/brain/awv040.
BibTeX
@article{rosalind2015Direct,
title = {Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain},
author = {Rosalind F. Roberts and Richard Wade‐Martins and Javier Alegre‐Abarrategui},
journal = {Brain},
year = {2015},
doi = {10.1093/brain/awv040},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Oxford University Research Archive (ORA) (University of Oxford) 2015
Preprint · OA
The role of alpha-synuclein oligomers in Parkinson's disease pathophysiology and biology
Acta Neuropathologica 2010
Open access · CC-BY
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
National Institute on Aging (NIA) 2005
Open access · US-GOV
Trial to Increase Walking Among Sedentary Older Latinos
Annals of Clinical and Translational Neurology 2016
Open access · CC-BY
Alpha‐synuclein RT ‐Qu IC in the CSF of patients with alpha‐synucleinopathies
Neural Regeneration Research 2021
Open access · CC-BY
Oral frailty and neurodegeneration in Alzheimer’s disease
Journal of Neuropathology & Experimental Neurology 2005
Open access · OA